Cargando…
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis
Alemtuzumab is a monoclonal antibody that binds to CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes are derived. It is currently used as an immune reconstitution therapy in patients with relapsing–remitting multiple sclerosis. Alemt...
Autores principales: | Rolla, Simona, Maglione, Alessandro, De Mercanti, Stefania Federica, Clerico, Marinella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348777/ https://www.ncbi.nlm.nih.gov/pubmed/32503344 http://dx.doi.org/10.3390/cells9061396 |
Ejemplares similares
-
The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
por: Maglione, Alessandro, et al.
Publicado: (2019) -
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up
por: Rolla, Simona, et al.
Publicado: (2022) -
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
por: Maglione, Alessandro, et al.
Publicado: (2021) -
Feeding the gut microbiome: impact on multiple sclerosis
por: Bronzini, Matteo, et al.
Publicado: (2023) -
Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies
por: Maglione, Alessandro, et al.
Publicado: (2022)